Showing results (331-340 of 561) with videos related to
Sort By:
Pageof 57
Clinical Colorectal Cancer|January 27, 2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008Timothy J Price, Niall C Tebbutt, Christos S Karapetis, et al.Neuroimage|April 21, 2006
A visual joke fMRI investigation into Theory of Mind and enhanced risk of schizophreniaDominic Marjoram, Dominic E Job, Heather C Whalley, et al.Clinical Colorectal Cancer|August 28, 2019
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UKShelize Khakoo, Ian Chau, Ian Pedley, et al.ESMO Open|November 16, 2016
Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trialSalvatore Siena, Josep Tabernero, Gyorgy Bodoky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid TumorsEric Van Cutsem, Boguslawa Karaszewska, Yoon-Koo Kang, et al.BMC Hematology|August 22, 2018
Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patientsAndrea Kühnl, David Cunningham, Margaret Hutka, et al.British Journal of Cancer|December 20, 2023
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trialBianca Grosser, Jake Emmerson, Nic G Reitsam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancerIan Chau, Gina Brown, David Cunningham, et al.Frontiers in Neuroscience|February 19, 2026
Evaluation of the myogenic effects of subthalamic nucleus deep brain stimulation at near therapeutic amplitudesCarmen Toth, Brett A Campbell, Leonardo Favi Bocca, et al.Cancer Treatment Reviews|April 12, 2020
Imaging and clinical correlates with regorafenib in metastatic colorectal cancerKhurum Khan, Stefano Cascinu, David Cunningham, et al.Pageof 57